FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912353690> ?p ?o ?g. }

• W2912353690 abstract "Objective: To evaluate efficacy of fremanezumab in patients with episodic migraine (EM) by assessing the change in use of acute headache medications. Background: Overuse of acute headache medications in people with EM can lead to worsening of headaches or transformation to chronic migraine. Fremanezumab (TEV-48125), a fully humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP), has proven efficacy in migraine prevention. Design/Methods: In this Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, eligible adult patients with prospectively confirmed EM (6–14 headache days and ≥4 migraine days per month) were randomized 1:1:1 to receive subcutaneous injections of fremanezumab monthly (225 mg at baseline, Weeks 4 and 8), fremanezumab quarterly (675 mg at baseline, and placebo at Weeks 4 and 8), or placebo at each time point over a 12-week treatment period. The monthly numbers of days on which patients used either acute headache medications of any type or those specific to migraine (triptans and ergots) were evaluated as secondary and exploratory endpoints. Results: 875 patients were randomized (monthly, N=290; quarterly, N=291; placebo, N=294). Both fremanezumab regimens significantly reduced the monthly number of days with use of any acute medication (monthly: −3.0±0.22 days; quarterly: −2.9±0.22 days;) versus placebo (−1.6±0.21 days) during the 12-week treatment period (both, P Conclusions: Fremanezumab reduces the need for acute headache and migraine-specific medication use in patients with EM. Study Supported by: This study was funded by Teva Pharmaceutical Industries, Petach Tikva, Israel. Disclosure: Dr. Brandes has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Advisory boards: Amgen, Lilly, Promius, Supernus; consulting for Amgen, Promius. Dr. Brandes has received research support from Amgen, Teva, Allergan, Colucid, Zotrip. Dr. Sakai has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals. Dr. Yeung has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals. Dr. Blankenbiller has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals. Dr. Grozinski-Wolff has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals. Dr. Yang has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals. Dr. Ma has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals. Dr. Aycardi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals. Dr. Bigal has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Pharmaceuticals." @default.
• W2912353690 created "2019-02-21" @default.
• W2912353690 creator A5005207942 @default.
• W2912353690 creator A5018344799 @default.
• W2912353690 creator A5019830062 @default.
• W2912353690 creator A5041587271 @default.
• W2912353690 creator A5044997689 @default.
• W2912353690 creator A5054958208 @default.
• W2912353690 creator A5057078715 @default.
• W2912353690 creator A5060701773 @default.
• W2912353690 creator A5078169327 @default.
• W2912353690 date "2018-04-10" @default.
• W2912353690 modified "2023-09-24" @default.
• W2912353690 title "Impact of Fremanezumab on the Number of Days With Use of Acute Headache Medications in Episodic Migraine (P4.106)" @default.
• W2912353690 hasPublicationYear "2018" @default.
• W2912353690 type Work @default.
• W2912353690 sameAs 2912353690 @default.
• W2912353690 citedByCount "0" @default.
• W2912353690 crossrefType "journal-article" @default.
• W2912353690 hasAuthorship W2912353690A5005207942 @default.
• W2912353690 hasAuthorship W2912353690A5018344799 @default.
• W2912353690 hasAuthorship W2912353690A5019830062 @default.
• W2912353690 hasAuthorship W2912353690A5041587271 @default.
• W2912353690 hasAuthorship W2912353690A5044997689 @default.
• W2912353690 hasAuthorship W2912353690A5054958208 @default.
• W2912353690 hasAuthorship W2912353690A5057078715 @default.
• W2912353690 hasAuthorship W2912353690A5060701773 @default.
• W2912353690 hasAuthorship W2912353690A5078169327 @default.
• W2912353690 hasConcept C118303440 @default.
• W2912353690 hasConcept C126322002 @default.
• W2912353690 hasConcept C141071460 @default.
• W2912353690 hasConcept C142724271 @default.
• W2912353690 hasConcept C163170386 @default.
• W2912353690 hasConcept C168563851 @default.
• W2912353690 hasConcept C170493617 @default.
• W2912353690 hasConcept C197934379 @default.
• W2912353690 hasConcept C203092338 @default.
• W2912353690 hasConcept C204787440 @default.
• W2912353690 hasConcept C27081682 @default.
• W2912353690 hasConcept C2777119127 @default.
• W2912353690 hasConcept C2778375690 @default.
• W2912353690 hasConcept C2778541695 @default.
• W2912353690 hasConcept C2778871607 @default.
• W2912353690 hasConcept C2778938600 @default.
• W2912353690 hasConcept C2780966972 @default.
• W2912353690 hasConcept C2910587157 @default.
• W2912353690 hasConcept C42219234 @default.
• W2912353690 hasConcept C71924100 @default.
• W2912353690 hasConceptScore W2912353690C118303440 @default.
• W2912353690 hasConceptScore W2912353690C126322002 @default.
• W2912353690 hasConceptScore W2912353690C141071460 @default.
• W2912353690 hasConceptScore W2912353690C142724271 @default.
• W2912353690 hasConceptScore W2912353690C163170386 @default.
• W2912353690 hasConceptScore W2912353690C168563851 @default.
• W2912353690 hasConceptScore W2912353690C170493617 @default.
• W2912353690 hasConceptScore W2912353690C197934379 @default.
• W2912353690 hasConceptScore W2912353690C203092338 @default.
• W2912353690 hasConceptScore W2912353690C204787440 @default.
• W2912353690 hasConceptScore W2912353690C27081682 @default.
• W2912353690 hasConceptScore W2912353690C2777119127 @default.
• W2912353690 hasConceptScore W2912353690C2778375690 @default.
• W2912353690 hasConceptScore W2912353690C2778541695 @default.
• W2912353690 hasConceptScore W2912353690C2778871607 @default.
• W2912353690 hasConceptScore W2912353690C2778938600 @default.
• W2912353690 hasConceptScore W2912353690C2780966972 @default.
• W2912353690 hasConceptScore W2912353690C2910587157 @default.
• W2912353690 hasConceptScore W2912353690C42219234 @default.
• W2912353690 hasConceptScore W2912353690C71924100 @default.
• W2912353690 hasLocation W29123536901 @default.
• W2912353690 hasOpenAccess W2912353690 @default.
• W2912353690 hasPrimaryLocation W29123536901 @default.
• W2912353690 hasRelatedWork W2800977241 @default.
• W2912353690 hasRelatedWork W2805440854 @default.
• W2912353690 hasRelatedWork W2805955440 @default.
• W2912353690 hasRelatedWork W2807266351 @default.
• W2912353690 hasRelatedWork W2808748844 @default.
• W2912353690 hasRelatedWork W2897284151 @default.
• W2912353690 hasRelatedWork W2900030708 @default.
• W2912353690 hasRelatedWork W2901040310 @default.
• W2912353690 hasRelatedWork W2915221528 @default.
• W2912353690 hasRelatedWork W2916037536 @default.
• W2912353690 hasRelatedWork W3006211681 @default.
• W2912353690 hasRelatedWork W3047736609 @default.
• W2912353690 hasRelatedWork W3093820723 @default.
• W2912353690 hasRelatedWork W3124573384 @default.
• W2912353690 hasRelatedWork W3154090263 @default.
• W2912353690 hasRelatedWork W3172467076 @default.
• W2912353690 hasRelatedWork W3191369108 @default.
• W2912353690 hasRelatedWork W3196376434 @default.
• W2912353690 hasRelatedWork W3210087989 @default.
• W2912353690 hasRelatedWork W3111739891 @default.
• W2912353690 hasVolume "90" @default.
• W2912353690 isParatext "false" @default.
• W2912353690 isRetracted "false" @default.
• W2912353690 magId "2912353690" @default.
• W2912353690 workType "article" @default.